News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard May 22, 2021 StatementCOVID-19 Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants in the United Kingdom Download May 21, 2021 StatementCOVID-19 Complete Trial Results Manuscript of Novavax COVID-19 Investigational Vaccine Posted to Preprint Server medRxiv Download May 21, 2021 StatementCOVID-19 Novavax Statement on Participation in Mix-and-Match COVID-19 Vaccine Booster Trial in the United Kingdom Download May 21, 2021 Corporate and finance Novavax Honored by Maryland Tech Council During 2021 Industry Awards Celebration Download May 10, 2021 Corporate and finance Novavax Reports First Quarter 2021 Financial Results and Operational Highlights Download May 10, 2021 StatementCOVID-19 Novavax Statement on Updated PREVENT-19 Trial Protocol Download May 10, 2021 COVID-19Seasonal influenza Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate Download May 7, 2021 StatementCOVID-19 Novavax Statement on Ministry of Health, Labour and Welfare’s Announcement Regarding Procurement from Takeda of NVX-CoV2373 for Japan Download May 7, 2021 StatementCOVID-19 Novavax Statement in Opposition to the WTO TRIPS Waiver Download May 6, 2021 COVID-19 Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility Download May 5, 2021 New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant Download May 3, 2021 Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine Download Apr 23, 2021 Novavax to Host Conference Call to Discuss First Quarter Financial Results and Operational Highlights on May 10, 2021 Download Apr 23, 2021 Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet Download Apr 14, 2021 COVID-19 Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations Download Apr 13, 2021 Corporate and finance Novavax Announces Leadership Updates Download Apr 8, 2021 Corporate and finance Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference Download Apr 5, 2021 Corporate and finance Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting Download Apr 5, 2021 COVID-19 Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover Download Mar 29, 2021 COVID-19 GSK to support manufacture of Novavax' COVID-19 vaccine Download Mar 11, 2021 COVID-19 Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials Download Mar 8, 2021 Corporate and finance Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat Download Mar 1, 2021 Corporate and finance Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights Download Feb 26, 2021 COVID-19 Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan Download Feb 22, 2021 COVID-19 Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico Download Feb 18, 2021 COVID-19 Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine Download Feb 16, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021 Download Feb 15, 2021 COVID-19 Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea Download Feb 4, 2021 COVID-19 Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization Download Feb 3, 2021 COVID-19 Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine Download Feb 2, 2021 COVID-19 Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada Download Feb 1, 2021 COVID-19 Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science Download Jan 28, 2021 COVID-19 Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial Download Jan 22, 2021 Corporate and finance Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management Download Jan 22, 2021 COVID-19 Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine Download Jan 15, 2021 Corporate and finance Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer Download Jan 7, 2021 COVID-19 Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine Download Jan 6, 2021 Corporate and finance Novavax to Participate in Upcoming Conferences Download Dec 28, 2020 COVID-19 Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico Download Dec 21, 2020 Corporate and finance Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer Download Dec 16, 2020 COVID-19 Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine Download Dec 9, 2020 Corporate and finance Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors Download Nov 30, 2020 COVID-19 Novavax Announces COVID-19 Vaccine Clinical Development Progress Download Nov 25, 2020 Corporate and finance Novavax to Participate in Upcoming Conferences Download Nov 10, 2020 Corporate and finance Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020 Download Nov 9, 2020 COVID-19 Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA Download Nov 9, 2020 Corporate and finance Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates Download Nov 9, 2020 Corporate and finance Novavax Reports Third Quarter 2020 Financial and Operational Results Download Nov 4, 2020 COVID-19 Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine Download Nov 3, 2020 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020 Download Show 5102550100 per page«123456789»